Login
Enter your username or email address
Enter the password that accompanies your username.

Request new password

Home

Progress in Mind SEA

  • Topics
    • Depression
    • Migraine
    • Schizophrenia
    • Parkinson's Disease
    • Alzheimer's Disease
    • Bipolar Disease
    • Anxiety
  • Congress Highlights
    • EAN 2023
    • WPA 2022
    • EPA 2022
    • APA 2022
    • EAN 2022
    • WCN 2021
    • ECNP 2021
    • IHC 2021
    • AAN 2021
    • AHS 2021
    • EPA 2021
    • WPA 2021
    • CINP 2021
  • BRAIN MASTER
  • ASK THE EXPERTS
  • About

Articles

LAI
  • Schizophrenia 08 Apr, 2022 Read Time: 3 mins
    Congress highlights Article

    Improving treatment adherence in patients with early-phase schizophrenia

    Early treatment engagement and a robust treatment response in patients with schizophrenia may be a...
  • Schizophrenia 12 Nov, 2021 Read Time: 4 mins
    Congress highlights

    Adherence in the real world

    Non-adherence and lack of engagement commonly mean that patients with serious mental illnesses may...
  • Schizophrenia, Alcohol Dependence 12 Nov, 2021 Read Time: 3 mins
    Congress highlights

    Decreasing relapse and rehospitalization in first-episode psychosis

    More than 50% of people with first-episode psychosis (FEP) have comorbid substance use disorder...
  • Schizophrenia 09 Feb, 2019 Read Time: 1 min
    Article

    Early use of a long acting injectable antipsychotic shortens hospital stay for acute schizophrenia

    Average hospital stay for patients treated with a long-acting injectable (LAI) antipsychotic...

Progress in Mind South East Asia

HCP Access Verification Required

To gain access, please provide details to verify you are a healthcare professional.

Register Login

If you are not located in South East Asia click here.

Brought to you by

Lundbeck

© 2022 Lundbeck SEA

PROGRESS IN MIND SOUTH EAST ASIA

Disclaimer and privacy statement

Cookies

About

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue